echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > These drugs are beginning to be reduced in price (with list)

    These drugs are beginning to be reduced in price (with list)

    • Last Update: 2021-01-20
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    375 collection of unseeded drugs will reduce prices recently, Jilin Province Public Resources Trading Center issued "on the publicity of the third batch of national organizations centralized procurement and use of drugs not selected Jilin Province and not selected and has participated in Jilin Province online procurement of some drug prices linked price reduction results notice."
    According to Cypress Blue combing, a total of 375 drugs began to link the price reduction, involving anatrophic tablets, apixaban tablets, oxycodone tablets, omeprazole intestinal tablets, ibuprofen slow-release capsules, capertabin tablets, Monrust sodium chewing tablets, fentanyl tablets, Hydrochloric metformin tablets, left ethyl elassitan injection with a thick solution, amoxicillin particles, fentanyl tablets, sildenafil tablets, hydrobrominate citrane tablets, cephalosporine dispersion tablets, hydrochloric acid left oxyfluorosa star drop eye fluid, injection with azatsin and so on.
    It is worth noting that many of the drugs that have been publicly priced are from well-known pharmaceutical companies, such as Hengrui, Shi medicine, Ha pharmaceutical, AstraZeneta, Sino-American Shanghai Shiguibao, Xi'an Yangsen, Pfizer, Shanghai Roche, Zhengda Tianqing, Shanghai Abbott Pharmaceuticals, Qilu Pharmaceuticals, China Resources Shuanghe, Merck Pharmaceuticals and so on.
    in addition, Micobao, Alto, Ding Ting Ting, Si Ruikang, Wan Aike and other outstanding foreign pharmaceutical companies well-known products are also on the list.
    Saibai Blue inquiry found that Jilin Provincial Health Insurance Bureau on October 29 issued "on the third batch of state-organized drugs centralized procurement and use of Jilin Province selected drugs and the failure to reduce the price of drugs" mentioned: "Shanghai Joint Procurement Office on August 24 issued the "National Drug Centralized Procurement" The 55 kinds of drugs involved in the list of selected varieties, which have not implemented price linkage and independent price reduction in Jilin Province, are not higher in principle than the national minimum transaction price of non-selected drugs (including the results of gradient price reductions in various places), and the results of the third batch of national centralized procurement in other provinces may not be collected.
    price reduction results of the implementation of the price limit online procurement."
    The latest landing situation of the third batch of collection on November 16, Hunan Province Public Resources Trading Center issued "on the implementation of the third batch of national collection of drugs in the selection of the results of the network procurement related to the preparation of the notice" clearly, by the end of November to complete the third batch of national collection of drugs in the selection of the results of the network procurement.
    Hunan Province's notice requirements, in Hunan Province, the selected enterprises before November 18 at 17:00 landing in Hunan Province pharmaceutical centralized procurement trading platform drug classification procurement trading system, confirmed that the selected drug packaging as a supply package, the drug other packaging quantity rules will be suspended hanging on the net;
    In addition, as of November 16, a total of 25 provinces and cities have identified the time for the implementation of the third batch of national harvest results - eight of which were implemented on November 1, namely Liaoning, Jiangsu, Shanxi, Qinghai, Guizhou, Chongqing, Hebei and Tianjin.
    15 other provinces and cities, Ningxia, Heilongjiang, Fujian, Henan, Shaanxi, Shanghai, Hainan, Sichuan, Jiangxi, Zhejiang, Guangdong, Shandong, Inner Mongolia, Xinjiang, Gansu, Hunan and Yunnan all implemented the results of the third batch of national elections in mid-to-late November.
    (watch making: Cypress blue) many asked the unseeded varieties to reduce prices according to Cypress blue combing, after confirming the province's third batch of national selection results implementation time, many places on the treatment of unseeded drugs made a notice.
    November 14, Hubei Province Pharmaceutical Price and Tender Procurement Management Service Network issued the "Notice on the confirmation of the third batch of national organizations centralized procurement of drugs non-selected varieties related information" pointed out that according to the third batch of national organizations centralized procurement of drugs (Hubei) selected varieties and non-selected varieties hanging network price adjustment, suspension of the hanging network and medical insurance payment standards during the publicity of the application (investment) and related documents, the relevant matters to be notified.
    the annex to the notice, Hubei also announced the third batch of national organizations to collect non-selected varieties of relevant information, no doubt these drugs also need to face price reduction, withdrawal of the network and other issues.
    On November 13, Tianjin Pharmaceutical Purchasing Center issued a notice on the price of the third batch of national drug centralized procurement of unelected varieties, saying that Tianjin organized the third batch of national drug centralized procurement of unelected varieties price adjustment work, in which the price of drugs that meet the requirements of the national collection of varieties declaration shall not be higher than the supply price of the varieties in other non-volume areas of the country;
    November 13, the Inner Mongolia Autonomous Region Procurement Network issued the "2020 Inner Mongolia Autonomous Region on the national organization of drug centralized procurement of unseeded drug price adjustment notice" said: encourage the non-selected drugs to reduce their own prices - the original research drugs, evaluation of preparations, imported drugs, through the quality and efficacy of consistent evaluation of imitation drugs in our region transaction prices shall not be higher than the lowest transaction prices in the provinces of the country.
    price adjustment, production enterprises should timely and actively declare the latest national minimum provincial transaction prices.
    addition, the purchase price of generic drug supply medical institutions that have not passed the evaluation of the consistency of quality and efficacy shall not be higher than the purchase price of the local selected drugs, and the purchase price shall be agreed by the medical institutions and enterprises themselves through the pharmaceutical procurement network of the autonomous region.
    November 13, Shanghai Sunshine Pharmaceutical Procurement Network issued "on the implementation of the third batch of national organizations in the centralized procurement of drugs selected results of the work tips" proposed that the declaration requirements for the same generic name did not select the highest price of drugs, sunshine platform will be unified to the procurement of the highest price of drugs medical institutions to push the gradient price reduction confirmed by enterprises and as a bargaining completion;
    other drugs that have not been selected, the Shanghai Pharmaceutical Institute pushes the "red line" of bargaining through the sun platform, and the actual purchase price is determined by the production enterprises and medical institutions in accordance with the provisions of the public bargaining.
    November 13, Jiangxi Province pharmaceutical procurement service platform also announced two batches of the third batch of non-selected drug prices in Jiangxi region of the declaration.
    addition to the above-mentioned areas, beijing, Hainan, Xinjiang, Shaanxi, Shandong, Guangdong and other places have made relevant provisions on the price reduction of drugs not selected.
    collection coverage share of large, high-amount products with the third batch of national mining landing, collection normalization and a new round of collection news has become the core of industry concern.
    On November 12, the State Health Insurance Administration mentioned in the Letter on the Reply to Proposal No. 3778 (Finance, Taxation and Finance No. 276) of the Third Session of the 13th National Committee of the CPPCC that the next step, in accordance with the Requirements of the Opinions of the State Council of the CPC Central Committee on Deepening the Reform of the Health Care System, the State Health Insurance Administration will adhere to the principle of one-size-fits-all, price-linked, and fully implement centralized procurement of medicines and medical supplies.
    On the basis of medical insurance payment, establish a provincial tender and procurement platform for bidding, procurement, transaction, settlement and supervision, promote the construction of a regional and national alliance procurement mechanism, form a fully competitive, reasonable price, standardized and orderly supply guarantee system, further strengthen the standardized construction of the operation of the centralized drug procurement platform, establish and improve unified basic operating rules, and further standardize the work flow and the rules for the withdrawal of the drug network.
    unswervingly, standardized and orderly promotion of centralized belt procurement, to clinical needs, quality-oriented, so that should be exhausted, will be collected to cover a large share of high-value products.
    the third batch of state-organized drug centralized procurement and use of drugs in Jilin Province was not selected and has participated in Jilin Province online procurement of some drug prices linked price reduction results
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.